MANAGEMENT OF DYSPNEA AND COUGH IN PATIENTS WITH CANCER
- 1 February 1996
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 10 (1) , 157-171
- https://doi.org/10.1016/s0889-8588(05)70332-4
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patientsThe Lancet, 1993
- Effects of Nebulized Morphine Sulfate on the Exercise Tolerance of the Ventilatory Limited COPD PatientChest, 1993
- Buspirone Effect on Breathlessness and Exercise Performance in Patients with Chronic Obstructive Pulmonary DiseaseRespiration, 1993
- Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: The use of the N of 1 randomized controlled trialJournal of Pain and Symptom Management, 1992
- Effects of morphine on the dyspnea of terminal cancer patientsJournal of Pain and Symptom Management, 1990
- Neurogenic plasma extravasation: inhibition by morphine in guinea pig airways in vivoJournal of Applied Physiology, 1988
- Opioid modulation of non‐cholinergic neural bronchoconstriction in guinea‐pig in vivoBritish Journal of Pharmacology, 1988
- Mechanisms of DyspneaClinics in Chest Medicine, 1987
- Reducing Ventilatory Response to Carbon Dioxide by Breathing Cold Air1–3American Review of Respiratory Disease, 1984
- The treatment of malignant pleural effusionsCancer, 1974